Angioplasty and stenting are here to stay, says expert cardiologist
Addressing a media conference here on Saturday, he said that the mode of treatment required, be it simple medication, coronary angioplasty or bypass surgery, would depend on the situation, taking into account the procedural risks, safety concerns, immediate and long term outcomes, and cost-effectiveness.
'However, currently the available stents are thin strut drug eluting stents (DES) that release special drug into the area of treatment, reducing the chance of reoccurrence of the blocks. Special guide wires and specialty microcatheters that help in crossing totally blocked and tough old blocks have increased their procedural success to more than 95 per cent,' Dr. Reddy explained.
The senior interventional cardiologist also pointed out the use of special balloons to treat the blocks, including very thin 0.75 mm tapered tip balloons to make way through even the toughest blocks, high and ultra-high pressure balloons, cutting balloons with special stainless steel micro blades, and scoring balloons that have Nitinol to crack hard lesions. 'We also have drug-coated balloons (DCB) to treat blocks which do not need stents to be placed,' he added.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
8 hours ago
- Business Standard
Apollo Hospitals Q1 profit rises 42%, plans Rs 7,600 cr bed expansion
Leading hospital chain Apollo Hospitals Enterprise has posted a 42 per cent rise in net profit during the first quarter of financial year 2025-26 to Rs 432.8 crore, compared to Rs 305.2 crore during the April–June quarter of the previous financial year. During the period under review, its consolidated revenues grew 15 per cent year-on-year to Rs 5,842.1 crore, compared to Rs 5,085.6 crore during the same quarter of FY25. EBITDA stood at Rs 852 crore versus Rs 675 crore in the first quarter of FY25. 'I am proud to see the resilient comeback in the first quarter of FY26, building on the strong foundation of Q4FY25. Our performance demonstrates the power and resilience of our integrated model of healthcare delivery, with all three engines — our core divisions, Healthcare Services, Retail Healthcare and Diagnostics, and Digital and Pharma Distribution — contributing to our performance,' said Prathap C Reddy, chairman, Apollo Hospitals Enterprise. As on June 30, Apollo Hospitals had 8,030 operating beds across the network (excluding AHLL and managed beds). The overall occupancy for hospitals was at 65 per cent compared to 68 per cent in the same period in the previous year. The quarter also saw the company announce its ambitious growth strategy to add over 4,300 beds in the next five years with an investment of over Rs 7,600 crore. 'The first phase of 2,000 beds is already in progress. We have added an existing 200-bed hospital in Bengaluru and will also be establishing a 500-bed greenfield hospital in the suburbs of the city to bring the total bed strength in Bengaluru to 1,500 beds,' Reddy said. In Hyderabad, it is adding 160 beds at the existing Jubilee Hills and Secunderabad facilities. With the upcoming facility in Gachibowli, the total bed count in the city will be 1,400 beds. 'The demerger of our digital health and pharmacy business, approved in the last quarter, is now in the implementation phase. This strategic move will enable focused capital allocation and sharper growth plans with dedicated management teams for both hospital operations and the omnichannel healthcare ecosystem — a structure designed to maximise synergies while preserving the Apollo ethos of quality and trust,' Reddy added. On the digital front, Apollo 24/7 achieved a quarterly gross merchandise value (GMV) of over Rs 682 crore, sustaining the platform's momentum and signalling continuing strong demand for teleconsultations, lab services and pharmacy deliveries. 'This performance builds on the platform's FY25 GMV of Rs 3,007 crore, demonstrating our success in creating a seamless care continuum from home to hospital,' he said.
Hans India
05-08-2025
- Hans India
BJP leader chosen for US leadership exchange programme
Kurnool: Dr Vinusha Reddy, State BJP spokesperson, has been selected as India's sole delegate for the 2025 International Visitor Leadership Programme (IVLP), a premier US State Department exchange initiative for emerging global leaders. The programme, themed 'Women in Politics and Civil Society', will run from August 9 to 30, involving delegates from 20 countries, including Japan, Germany, and South Africa. Dr Reddy will visit US cities like Washington DC, Boston, and Salt Lake City, engaging with lawmakers, civic groups, and women leaders. Highlights include a Gallup leadership workshop and discussions on gender parity in politics. Medical practitioner and author Dr Vinusha Reddy manages a hospital in Kurnool and wrote 'India Before & After 2014: Why Bharat Needs BJP?'. She previously represented India at the 2023 BRICS Political Parties Dialogue Summit in South Africa, contributing to the summit resolution. Her IVLP selection aligns with India's push for women's representation, including the proposed 33% reservation for women in the 2029 elections. Dr. Reddy thanked the BJP and PM Narendra Modi for supporting women's leadership, noting the honor of joining IVLP alumni like Indira Gandhi and Modi in fostering global dialogue. Speaking to The Hans India on Monday ahead of her visit, Dr Reddy thanked BJP and Prime Minister Narendra Modi for championing women's leadership. 'This is not just a personal honour but a recognition of BJPs commitment to empowering new voices, especially women,' she said.
The Hindu
04-08-2025
- The Hindu
Bangalore Gastro Centre Sets a New Benchmark in Digestive Healthcare in India
Bangalore Gastro Centre (BGC) Hospitals, Karnataka's NABH-accredited standalone Medical Gastroenterology Institute, has been recognised as South India's Best Hospital for Gastroenterology at the Asia Health Awards 2024. Founded in 2022 by internationally trained & renowned gastroenterologist Dr. Yogananda Reddy, BGC is redefining digestive healthcare in India through patient-first innovations, research collaborations, and community-focused care. Leading the Way in Specialised Digestive Care With digestive disorders on the rise due to lifestyle changes, BGC has emerged as a Centre of Excellence offering specialised care through its Medical, Surgical, and Paediatric Gastroenterology departments. The facility is equipped with advanced diagnostic and therapeutic capabilities, including: ● Endoscopy suites for EUS, ERCP, gastroscopy, and colonoscopy ● Sub-speciality clinics for IBD, hepatology, neuro-gastroenterology and paediatric gastroenterology 'We've built BGC on the principle of combining global standards with compassionate, accessible gastroenterology care,' said Dr. Yogananda Reddy, Chief Gastroenterologist and Director. 'Our patient-first approach is what sets us apart—from protocol-driven treatments to ensuring patients feel heard and respected.' Extended Access Through 7-Day Specialist OPD Services One of BGC's most impactful initiatives is the launch of 7-day OPD services, including Sundays—offering direct access to super-specialist gastroenterologists. This move addresses the needs of working professionals who often delay treatment due to weekday commitments, enabling timely diagnosis and intervention. Free Rural Outreach Programme Across Karnataka Demonstrating its commitment to equitable healthcare, BGC has also rolled out a self-funded Free Rural Outreach Digestive Health Programme, bringing superspecialist care to underserved areas. This outreach initiative not only delivers the much needed Gastrointestinal care but also raises awareness on preventive digestive health. Driving Research in Gut Health with South Korea's 3BIGS In a step toward personalised medicine, BGC has signed an MoU with South Korean biodata firm 3BIGS for joint research on the gut microbiome, using AI-driven analytics. This project aims to decode the complex role of gut microbes in Indian patients and create predictive, personalised treatment strategies for conditions like IBS and inflammatory disorders. 'The future of gastroenterology lies in proactive, data-led care. Our collaboration with 3BIGS will help us lead that change in India,' added Dr. Reddy. Surgical Gastroenterology Care & Oncology Expansion A new dedicated Surgical Gastroenterology & Oncology block, started recently has expanded the centre's cancer treatment capabilities with integrated diagnostics, 24/7 surgical gastroenterology care, and recovery pathways. Recognition and Awards Under Dr. Reddy's leadership—who previously served as a consultant gastroenterologist in the UK's NHS—BGC has quickly gained national recognition. The centre was named: ● Single Speciality Hospital of the Year (2023–2024) at the India Excellence Awards ● Excellence in Gastroenterology by Times of India (2024) ● Top 3 finalist for Hospital of the Year – Gastroenterology at the Economic Times Health Awards (2024) About Bangalore Gastro Centre Hospitals Bangalore Gastro Centre Hospitals is a dedicated super-speciality hospital focused exclusively on digestive health. Through international-standard treatment protocols, cutting-edge diagnostics, ongoing research, and inclusive care models, BGC is transforming gastroenterology services in India. For media inquiries or more information, visit: 'This is a company press release that is not part of editorial content. No journalist of The Hindu was involved in the publication of this release.'
